Literature DB >> 16690159

Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country: experience of a university teaching hospital.

Chong-Kin Liam1, Yong-Kek Pang, Chai-Hooi Leow, Shyamala Poosparajah, Ashoka Menon.   

Abstract

A comparison of patients with lung cancer diagnosed at the University of Malaya Medical Centre, Kuala Lumpur, Malaysia from October 1991 to September 1999 with another group of lung cancer patients diagnosed at the same hospital during an earlier period of 1967-1976 was undertaken to determine whether there had been a change in the distribution of lung cancer cell types and patient demography. The number of histologically and/or cytologically proven lung cancer cases was 583 from October 1991 to September 1999 and 278 from 1967 to 1976. The mean (S.D.) age of the patients during the period 1991-1999, 60.1 (12.0) years was similar to that of patients during the period 1967-1976, 60.3 (12.2) years. There was no shift of the peak age distribution of lung cancer (i.e., the 7th decade) between the two periods. In the recent period, the percentage of patients with adenocarcinoma had increased significantly to 43.2% from 25.2% while that of large cell carcinoma had decreased to 3.3% from 11.9%. The percentages of patients with squamous cell carcinoma (SCC) and small cell lung cancer remained stable. In the period 1967-1976, SCC was the commonest cell type in men and in smokers while adenocarcinoma was the commonest cell type in women and in never smokers. In the period 1991-1999, adenocarcinoma was the commonest cell type in both men and women as well as in smokers and never smokers.

Entities:  

Mesh:

Year:  2006        PMID: 16690159     DOI: 10.1016/j.lungcan.2006.03.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.

Authors:  Daiki Miki; Michiaki Kubo; Atsushi Takahashi; Kyong-Ah Yoon; Jeongseon Kim; Geon Kook Lee; Jae Ill Zo; Jin Soo Lee; Naoya Hosono; Takashi Morizono; Tatsuhiko Tsunoda; Naoyuki Kamatani; Kazuaki Chayama; Takashi Takahashi; Johji Inazawa; Yusuke Nakamura; Yataro Daigo
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 3.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 4.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

5.  Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.

Authors:  Norahayu Othman; Lionel L A In; Jennifer A Harikrishna; Noor Hasima
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

6.  Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study.

Authors:  Kun Wang; Likwang Chen; Chi-Kuei Hsu; Chih-Cheng Lai
Journal:  PeerJ       Date:  2016-12-20       Impact factor: 2.984

7.  Cluster Analysis Evaluating PM2.5, Occupation Risk and Mode of Transportation as Surrogates for Air-pollution and the Impact on Lung Cancer Diagnosis and 1-Year Mortality.

Authors:  Sopian Abdul Wahab; Astrid Hassan; Mohd Talib Latif; Yasheeny Vadiveel; Tamyenthini Jeyabalan; Chun Ian Soo; Faisal Abdul Hamid; Andrea Ban Yu-Lin; Tidi Hassan
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

8.  The performance of NLST screening criteria in Asian lung cancer patients.

Authors:  Vivek Kumar; Kevin Becker; Huo Xiang Zheng; Yiwu Huang; Yiqing Xu
Journal:  BMC Cancer       Date:  2015-11-18       Impact factor: 4.430

9.  Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study.

Authors:  Matin Mellor Abdullah; Amit Bhat; Ahmad Kamal Mohamed; Foo Yoke Ching; Nida Ahmed; Sandeep Gantotti
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

10.  Epidermal Growth Factor Receptor Gene Mutation Detection in Histology and Cytology Specimens of Primary Lung Adenocarcinoma: Immunohistochemistry Versus the Molecular Method.

Authors:  Nurul Shuhada Abdul Hamid; Anani Aila Mat Zin
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.